Genenta Science SPA (Genenta Science SPA) Research & Development : $7.03 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Genenta Science SPA's Research & Development for the six months ended in Dec. 2023 was $2.78 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $7.03 Mil.

Genenta Science SPA Research & Development Historical Data

The historical data trend for Genenta Science SPA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Research & Development Chart

Genenta Science SPA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

4.11

5.70

3.83

5.66

7.06

Genenta Science SPA Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Research & Development	Get a 7-Day Free Trial				0.22	1.74	3.92	4.25	2.78

Genenta Science SPA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $7.03 Mil.

Genenta Science SPA (NAS:GNTA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genenta Science SPA Research & Development Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

K5F:Germany

Address

Via Olgettina No. 58, Milan, ITA, 20132

Website

https://www.genenta.com

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.